发明名称 |
Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof |
摘要 |
Long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer are provided. In particular, the long acting pharmaceutical composition comprises a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection. |
申请公布号 |
US8796226(B2) |
申请公布日期 |
2014.08.05 |
申请号 |
US201013258808 |
申请日期 |
2010.08.19 |
申请人 |
Mapi Pharma Ltd. |
发明人 |
Marom Ehud;Rubnov Shai |
分类号 |
A61K38/16;A61K38/10;A61K38/02;A61K9/19;C07K14/00;A61K9/00;A61K9/16 |
主分类号 |
A61K38/16 |
代理机构 |
Rothwell, Figg, Ernst & Manbeck, P.C. |
代理人 |
Rothwell, Figg, Ernst & Manbeck, P.C. |
主权项 |
1. A long acting parenteral pharmaceutical composition comprising a therapeutically effective amount of a pharmaceutically acceptable salt of glatiramer, the composition being in a sustained release depot form which releases a therapeutically effective amount of the pharmaceutically acceptable salt of glatiramer over a period of about 1 week to about 6 months,
the pharmaceutical composition further comprising at least one additional drug. |
地址 |
Ness Ziona IL |